High sclerostin expression has been shown to be associated with breast cancer bone metastasis; perhaps most interestingly in light of findings presented within this study, sclerostin has been shown to interact with STAT3 to enhance TGF-β/K-Ras signalling [33]. Here, STAT3 is linked to breast carcinoma.